A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...

Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...

November is Alzheimer’s Awareness Month and New York has the second highest rate of Alzheimer’s disease in the U.S. NYC’s ...

We are making progress in the fight against Alzheimer’s disease. The human brain is complex, but prioritizing Alzheimer’s ...

November is Alzheimer’s Awareness Month. According to the Alzheimer’s Association Mississippi Chapter, nearly 7 million ...

Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...

Researchers have revealed the role of enzyme TYK2 in the aggregation of tau proteins, which contributes to Alzheimer’s ...

Having a loved one with Alzheimer’s is incredibly taxing, both emotionally and physically. It’s OK to ask for help.

In honor of National Caregivers Month (November), we connected with Crystal Williams, associate vice president and assistant ...

Researchers have revealed how two neural circuits located in the brain's retrosplenial cortex are directly linked to spatial navigation and memory storage. This discovery could lead to more precise ...

“This can benefit us if we have hypochlorhydria or lack of stomach acid because it will acidify the stomach to help us digest ...

Understand Alzheimer's disease Alzheimer's disease is the leading cause of dementia, accounting for approximately 80% of ...